Form 4: Accenture Executive Joel Unruch Reports Share Transactions
SEC Form 4 Filing
Joel Unruch, General Counsel/Corporate Secretary of Accenture plc, reports transactions involving Class A ordinary shares, including purchases and grants, through the Accenture Voluntary Equity Investment Program.
Summary
- On January 5, 2025, Joel Unruch, General Counsel/Corporate Secretary of Accenture plc, reported transactions involving the company's Class A ordinary shares.
- These transactions include the purchase of 78 shares at $351.955 per share through the Accenture Voluntary Equity Investment Program.
- Additionally, Mr. Unruch received a grant of 581 shares under the same program.
- 723 shares were disposed of at $351.955.
- Following these transactions, Mr. Unruch beneficially owns 25,276 Class A ordinary shares.
Sentiment
Score: 5
Explanation: The document is a neutral report of stock transactions. It doesn't convey any explicit positive or negative sentiment about the company's performance or future prospects.
Positives
- The reporting person is actively participating in the Accenture Voluntary Equity Investment Program, indicating confidence in the company's future.
Industry Context
This filing is a routine disclosure of insider transactions, which are common for executives at publicly traded companies like Accenture. These transactions are part of standard compensation and investment programs.
Comparison to Industry Standards
- Executive compensation packages often include equity-based incentives to align management's interests with those of shareholders.
- The Accenture Voluntary Equity Investment Program is similar to employee stock purchase plans offered by other large corporations, such as Microsoft, Apple, and Google.
- These programs typically allow employees to purchase company stock at a discounted rate or receive grants as part of their compensation.
Stakeholder Impact
- The transactions may have a minor impact on shareholders by slightly increasing the number of outstanding shares.
Key Dates
| Date | Description |
|---|---|
| 01/05/2025 | Date of transactions: purchase of shares, grant of shares, and disposal of shares. |
| 01/06/2025 | Date of signature for the report. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.